Seeking Alpha

An FDA advisory panel has given qualified approval to Abbott's (ABT) minimally invasive...

An FDA advisory panel has given qualified approval to Abbott's (ABT) minimally invasive MitraClip device for closing up leaky heart valves. The committee voted unanimously that the implant is safe, but only 5-3 that the benefits outweigh the risks and 5-4 against the product being effective. On Monday, FDA staff said there's not enough data to prove MitraClip's effectiveness or safety.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)